RPL22 and cancer: RPL22 is frequently inactivated or deleted in primary cancer samples (Kandoth et al., 2013; Goudarzi and Lindström, 2016; Ghandi et al., 2019), as well as 7% of lines in the CCLE (Cao et al., 2017).